AES Clean Technology appoints new Vice President of Engineering

AES Clean Technology appoints new Vice President of Engineering  Montgomeryville, Pennsylvania, February 20th, 2024: AES Clean Technology, a leading provider of high-performance modular cleanroom facilities, has appointed Chris Barbieri as Vice President of Engineering. With over 20 years of experience in the life science industry and deep expertise in engineering and project delivery, Chris will oversee all aspects of engineering operations, including product development, innovation, and technological advancement initiatives that are aligned with AES’ strategic vision. In addition, he will focus on streamlining the team’s processes, driving consistency, and fostering a culture of technical excellence and innovation.

Horizon CME Announces First Annual Summit for Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer)

Horizon CME has announced its sponsorship of the first annual summit for the multidisciplinary conference, Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer).

ENPICOM partners with Erasmus University Medical Center in groundbreaking effort to discover nanobodies against cancer

ENPICOM has announced a collaboration with Erasmus Medical Center. This partnership aims to identify and develop nanobodies against cancer by utilizing ENPICOM’s immune repertoire data analysis services and software solutions.

The Rise of Digital Biomarkers: Revolutionizing Healthcare Monitoring

The global digital biomarkers market showcased remarkable growth, reaching a valuation of USD 3.55 billion in 2023. Projections indicate an exponential trajectory, with expectations to soar to approximately USD 26.79 billion by 2033. This impressive growth is anticipated to occur at a robust compound annual growth rate (CAGR) of 22.4% during the forecast period spanning from 2024 to 2033.

Novel Drug Delivery System Unveiled: CD Formulation Launches Oral Thin Films Technology

Alfa Chemistry Unveils Expanded Assortment of Derivatization Reagents for Use in Gas Chromatography (GC)

CD BioSciences Announces Its Self-Developed Alginate Products, Looking to Fulfill Research Needs

CD BioSciences is pleased to announce the launch of their latest self-developed alginate products, looking to fulfill scientific research demands.

Biomaterials, Another Key Player in Advanced Drug Delivery Systems, Interact Seamlessly with Biological Systems, Facilitating the Controlled Release of Medications

In the fight against infectious diseases like HIV/AIDS, tuberculosis, and viral hepatitis, scientists are turning to advanced drug delivery for more effective treatments. These systems use tiny particles called nanoparticles to carry antiviral and antimicrobial drugs directly to the infected tissues in the body. By doing this, they can target the specific areas where the viruses or bacteria are causing harm while reducing the risk of side effects in other body parts.

Amerigo Scientific Launches DOPC Nanodiscs as An Invaluable Tool for Handling Membrane Proteins

New Guidance Published in The Lancet Recommends Early Intervention and Use of BIS to Reduce Impact of Arm Lymphedema on Breast Cancer Patients

New Guidance Published in The Lancet Recommends Early Intervention and Use of BIS to Reduce Impact of Arm Lymphedema on Breast Cancer Patients

SinguLab® Announces Integration with PointClickCare

Precision medicine and diagnostics solutions company SinguLab has partnered with PointClickCare Technologies Inc., provider of a cloud-based software platform for the senior care continuum, to improve precision care capabilities and access in the long-term and post-acute care (LTPAC) space.

Eagle Product Inspection Highlights the Pack 320 PRO X-ray Machine

Superior x-ray inspection of high-speed flow-wrap lines

Optibrium enables collaborative design in its StarDrop platform

Optibrium today announced the release of StarDrop 7.6, the latest version of its platform for small molecule design, optimisation and analysis. As part of the release, Optibrium introduces a new extension, Idea Tracker, with which medicinal chemists can now easily trace molecular design and optimisation decisions through every step of the complex discovery process, from idea conception to selecting candidates for synthesis.

REMEDI8 Highlights Mobile Containment Unit for Infection Control in the Healthcare Industry

HEPA-10X mitigates the spread of infection in high-risk healthcare environments

Thermo Fisher Scientific Launches New Ion Chromatography Instrument to Improve Reliability, Efficiency, and Functional Adaptability for Labs

New Thermo Scientific Dionex Inuvion Ion Chromatography System streamlines ion analysis and expands analytical testing capabilities for ionic and small polar compounds

PrecisionLife and Metrodora Institute Partner to Accelerate the Diagnosis and Treatment of Long COVID, ME/CFS, and other Chronic Conditions

PrecisionLife and Metrodora Institute are co-investing in a first-of-its-kind partnership to jumpstart the diagnosis and treatment options for a range of complex, chronic diseases including Long COVID, ME/CFS, ALS, Sjögren's syndrome, and many more.

Alzheimer’s Research & Therapy: Linus Health Digital Clock and Recall Test Detects Early Cognitive Impairment in Over 80% of Patients Who Were Misclassified in Commonly Used Paper-Based Test

Alzheimer’s Research & Therapy: Linus Health Digital Clock and Recall Test Detects Early Cognitive Impairment in Over 80% of Patients Who Were Misclassified in Commonly Used Paper-Based Test

Personalized Health Basel and Leading Life Sciences Organization Collaborate with MDClone to Drive Innovation

Personalized Health Basel and Leading Life Sciences Organization Collaborate with MDClone to Drive Innovation

HM Lord-Lieutenant of Cambridgeshire Opens Domainex’s New Biology Centre of Excellence and Presents the King’s Award for Enterprise

Domainex, a leading drug discovery and integrated medicines research partner based in Cambridge UK, opens a new Biology Centre of Excellence to further support collaborations with pharmaceutical and biotechnology companies, patient foundations and leading academic institutions globally.

Monoclonal Antibodies Stand as Beacons of Hope in Cancer Treatment, Offering Remarkable Advancements in the Fight Against this Relentless Disease!

In 2022, the latest data from the International Agency for Research on Cancer's Global Cancer Observatory indicates that ten specific types of cancer collectively represented approximately two-thirds of both new cases and fatalities worldwide. Covering 185 countries and 36 different types of cancer, the rising demand for biologics, including monoclonal antibodies and immunotherapies, has surged due to the increasing incidence of cancer. These innovative treatments are revolutionizing cancer care by enhancing survival rates and minimizing adverse effects.